Fig. 3.
Viral and biochemical kinetics observed during 48 weeks of treatment with BLV alone (BLV) or in combination with Peg-IFN (BLV + Peg-IFN).
ALT, alanine transaminase; BLV, bulevirtide; Peg-IFN, pegylated interferon.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.